1. Academic Validation
  2. Homology modeling of human Fyn kinase structure: discovery of rosmarinic acid as a new Fyn kinase inhibitor and in silico study of its possible binding modes

Homology modeling of human Fyn kinase structure: discovery of rosmarinic acid as a new Fyn kinase inhibitor and in silico study of its possible binding modes

  • J Med Chem. 2007 Mar 22;50(6):1090-100. doi: 10.1021/jm0607202.
Dubravko Jelić 1 Boris Mildner Sanja Kostrun Krunoslav Nujić Donatella Verbanac Ognjen Culić Roberto Antolović Wolfgang Brandt
Affiliations

Affiliation

  • 1 GlaxoSmithKline Research Centre Zagreb, Prilaz baruna Filipovića 29, 10000 Zagreb, Croatia.dubravko.x.jelic@gsk.com
Abstract

Tyrosine phosphorylation represents a unique signaling process that controls metabolic pathways, cell activation, growth and differentiation, membrane transport, Apoptosis, neural, and Other functions. We present here the three-dimensional structure of Fyn tyrosine kinase, a Src-family Enzyme involved in T-cell receptor signal transduction. The structure of Fyn was modeled for homology using the Sybyl-Composer suite of programs for modeling. Procheck and Prosa II programs showed the high quality of the obtained three-dimensional model. Rosmarinic acid, a secondary metabolite of herbal Plants, was discovered as a new Fyn kinase inhibitor using immunochemical and in silico methods. Two possible binding modes of rosmarinic acid were evaluated here, i.e., near to or in the ATP-binding site of kinase domain of Fyn. Enzyme kinetic experiments revealed that Fyn is inhibited by a linear-mixed noncompetitive mechanism of inhibition by rosmarinic acid. This indicates that rosmarinic acid binds to the second "non-ATP" binding site of the Fyn tyrosine kinase.

Figures